Ratnani Iqbal, Tuazon Divina, Zainab Asma, Uddin Faisal
HOUSTON METHODIST HOSPITAL, HOUSTON, TEXAS.
Methodist Debakey Cardiovasc J. 2018 Apr-Jun;14(2):110-119. doi: 10.14797/mdcj-14-2-110.
Use of extracorporeal membrane oxygenation (ECMO) has been exponentially increasing over the last decade and is now considered a mainstream lifesaving treatment modality in critical care medicine. However, the need for physician education, training, and experience remains imperative. Although ECMO has traditionally been used in end-stage lung disease and circulatory collapse, it is being adopted for use in right heart failure, as a bridge to heart and lung transplantation, and as rescue therapy for both sepsis and post-organ transplantation. The following article discusses indications, management, complications, and challenges of ECMO as well as our experience at the Houston Methodist DeBakey Heart & Vascular Center.
在过去十年中,体外膜肺氧合(ECMO)的使用呈指数级增长,现已被视为危重症医学中一种主流的挽救生命的治疗方式。然而,医生教育、培训和经验的需求仍然至关重要。尽管ECMO传统上用于终末期肺病和循环衰竭,但它正被应用于右心衰竭,作为心脏和肺移植的桥梁,以及作为脓毒症和器官移植后的挽救治疗。以下文章讨论了ECMO的适应症、管理、并发症和挑战,以及我们在休斯顿卫理公会德巴凯心脏与血管中心的经验。